News UK budget includes £1bn biopharma investment package UK Chancellor John Healey's first Budget speech included a £1bn-plus industry investment package at sites in Manchester, Oxford, and Loughborough.
News Novavax critic Shah Capital ends its activism campaign Shah Capital has ended attempts to exert influence over vaccine firm Novavax, bringing more than years of pressure on management to an end.
News FTC says Shkreli is flouting lifetime pharma ban The FTC and several US states have accused Martin Shkreli of violating a lifetime order preventing him from involvement in the pharma industry.
News AstraZeneca cuts ribbon on new R&D facility in Massachusetts AstraZeneca's has opened a new R&D centre in the biotech hotspot of Cambridge, Massachusetts, the centrepiece of a $1bn investment in the state.
News Bayer pledges $2.2bn to US manufacturing facility Bayer has joined the ranks of pharma groups planning major facility investments in the US, with a $2.2bn plan for a new production unit in Ohio.
News Pharma leaders urge Europe to halt 'slow agony' of decline Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.